Home › Melanoma › Washington › Seattle

Pag-aaral pangklinika para sa Melanoma sa Seattle, WA

16 pag-aaral para sa Melanoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Seattle (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Nagre-recruitPhase 3

Swedish Cancer Institute, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06246916

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Swedish Medical Center-Ballard Campus, Seattle
Swedish Medical Center-Cherry Hill, Seattle
Swedish Medical Center-First Hill, Seattle
at 1 pa

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05334069

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Nagre-recruitObservasyonal na pag-aaral

Swedish Medical Center-Ballard Campus, Seattle
Kaiser Permanente Washington, Seattle
Swedish Medical Center-First Hill, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06418204

A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Nagre-recruitPhase 2

Local Institution - 0086, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07492680

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

Nagre-recruitPhase 1/2

University of Washington Fred Hutchinson Cancer Center, Seattle

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 6, 2026 · NCT06814496

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Nagre-recruitPhase 3

Fred Hutchinson Cancer Center, Seattle
University of Washington Medical Center - Montlake, Seattle
Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale · 17 mi ang layo

Edad 75 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07068074

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Nagre-recruitPhase 2

Swedish Medical Center-Ballard Campus, Seattle
Swedish Medical Center-Cherry Hill, Seattle
Swedish Medical Center-First Hill, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT04511013

Project: Every Child for Younger Patients With Cancer

Nagre-recruitObservasyonal na pag-aaral

Seattle Children's Hospital, Seattle

Hanggang edad 25 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT02402244

High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial

Nagre-recruit

Fred Hutch/University of Washington Cancer Consortium, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT06298734

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Nagre-recruitPhase 1

Fred Hutch/University of Washington Cancer Consortium, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT05098210

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Nagre-recruitPhase 1/2

Virginia Mason Medical Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update May 15, 2026 · NCT05379985

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Nagre-recruitPhase 1/2

Fred Hutchinson Cancer Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update May 13, 2026 · NCT03686124

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Nagre-recruitPhase 2/3

Fred Hutchinson Cancer Center, Seattle

Lahat ng edad · Lahat ng kasarian · Na-update Abr 2, 2026 · NCT06581406

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Nagre-recruitPhase 3

Fred Hutchinson Cancer Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 25, 2026 · NCT05549297

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Seattle

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

A Study of IBI363 in Subjects with Advanced Solid Malignancies

Nagre-recruitPhase 2

Fred Hutchinson Cancer Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Dis 19, 2024 · NCT06281678

Pag-aaral para sa Melanoma sa ibang lungsod

Iba pang pag-aaral sa Seattle

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.